Skip to main content
. 2006 Jul 12;117(2):117–129. doi: 10.1016/j.vetmic.2006.06.006

Table 1.

P-PMOs and their target sites in PRRSV RNAa,b

P-PMO name P-PMO sequence (5′–3′) Nucleotide position of P-PMO target in PPRSV RNA, and P-PMO orientation P-PMO target region in PRRSV
5UP1 CATAGAGCCAACACCTATACG 3–23, antisense 5′-terminus of genomic RNA
NSP1 CCCAAAAACTTGCTGCACGG 66–85, sense 3′-end-region of negative-sense (antigenome) RNA
TRS-Pc,d GACATGGTTAAAGGGGTGGAG 173–193, antisense TRS-region and 5′-end of ORF1a
TRSsg-Pd GGTTAAAGGGGTGGAGAGACCG 167–188, antisense TRS and TRS 5′-flanking sequence
ORF1aPc CCGATCAAGTATCCCAGACAT 189–209, antisense Translation initiation region of ORF1a
3UP1 GTCGCCCTAATTGAATAGGTG 15032–15052, antisense 3′-end-region of genomic RNA
CP1 GATATACACAACACCCAATT None Random sequence negative control
a

The peptide R5F2R4 is conjugated to the 5′-end of all the P-PMOs in this study.

b

P-PMO design was based on PRRSV VR2385 genomic RNA.

c

The underlined nucleotides correspond to the AUG translation initiation codon of PRRSV ORF1a.

d

The italicized nucleotides correspond to the ‘transcription regulatory sequence’.